JPRN-UMIN000014984
Completed
未知
Development of treatment effect prediction method of oral appliance therapy for obstructive sleep apnea syndrome - Development of treatment effect prediction method of oral appliance therapy for obstructive sleep apnea syndrome
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tokyo Medical and Dental University
- Enrollment
- 27
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients who have chronic nasal congestion, a high degree of tonsillar hypertrophy 2\.Patients who will be received combined OA and nCPAP therapy 3\.Patients who have received drug therapy related sleep (hypnotic, anxiolytic) 4\.Diagonsed as mental disorders or temporomandibular disorders. 5\.Patients who have a complication or history of respiratory disease. 6\.Patients who have an allergy against steroids or vasoconstrictor. 7\.Patients who need dental treatment for caries and periodontal disease in oral cavity
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Investigation of method for prediction of therapeutic effect of adalimumab initial therapy for inflammatory bowel diseaselcerative colitis, Crohn's diseaseJPRN-UMIN000022727Ofuna Chuo Hospital20
Completed
Not Applicable
Investigation of method for prediction of therapeutic effect of infliximab initial therapy for inflammatory bowel diseaselcerative colitis, Crohn's diseaseJPRN-UMIN000022726Ofuna Chuo Hospital20
Recruiting
Not Applicable
Evaluating treatment outcomes for adolescents with eating disorderseating disordersMental Health - Eating disordersACTRN12624000489594Children's Health Queensland Hospital and Health Service300
Recruiting
Not Applicable
Prediction of liver cancer treatment efficacy by CTC.Cases of unresectable advanced hepatocellular carcinoma (HCC) for which treatment with immune checkpHepatocellular carcinoma, Immune checkpoint inhibitors, Circulating tumore cellsJPRN-jRCT1061230098Sugihara Takaaki20
Completed
Not Applicable
Prediction of the therapeutic response and adverse events to methotrexate by monitoring methotrexate-polyglutamates (MTX-PGs) concentration in erythrocytes in Japanese patients with rheumatoid arthritis (RA).JPRN-UMIN000020134Jichi Medical University56